OTCMKTS:RNUGF ReNeuron Group (RNUGF) Stock Forecast, Price & News $0.09 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$0.09▼$0.0950-Day Range$0.07▼$0.0952-Week Range$0.07▼$0.34VolumeN/AAverage VolumeN/AMarket Capitalization$5.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About ReNeuron Group (OTCMKTS:RNUGF) StockReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.Read More RNUGF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RNUGF Stock News HeadlinesApril 3, 2023 | proactiveinvestors.comReNeuron appoints new scientific advisory boardFebruary 17, 2023 | proactiveinvestors.comReNeuron has extended cash runway as it focuses on validating its exosome platformOctober 1, 2023 | Stansberry Research (Ad)Are "The Magnificent Seven" the Next Sears?The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.December 8, 2022 | proactiveinvestors.comReNeuron says positive iPSC data presented at conferenceDecember 8, 2022 | proactiveinvestors.comReNeuron Group says positive iPSC data presented at conferenceDecember 2, 2022 | proactiveinvestors.comReNeuron unveils jump in revenue for first-half of 2022; issues a funding updateNovember 3, 2022 | finance.yahoo.comReNeuron Group (RENE): Re-initiation - Rebranding in Exosome Targeted Drug DeliverySeptember 14, 2022 | markets.businessinsider.comReNeuron Group Names John Hawkins CFO - Quick FactsOctober 1, 2023 | Stansberry Research (Ad)Are "The Magnificent Seven" the Next Sears?The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.April 29, 2021 | finance.yahoo.comWe Think ReNeuron Group (LON:RENE) Needs To Drive Business Growth CarefullyJanuary 19, 2021 | finance.yahoo.comWhat Is The Ownership Structure Like For ReNeuron Group plc (LON:RENE)?January 15, 2021 | finance.yahoo.comReNeuron Group (RENE): Continuing to Gain Clinical Data in Eye DiseaseJune 17, 2020 | finance.yahoo.comReNeuron Provides Program and Regulatory Approvals UpdateApril 6, 2020 | finance.yahoo.comReNeuron Update Regarding COVID-19January 20, 2020 | finance.yahoo.comHow Much Are ReNeuron Group plc (LON:RENE) Insiders Spending On Buying Shares?December 5, 2019 | finance.yahoo.comHow Much Did ReNeuron Group plc's (LON:RENE) CEO Pocket Last Year?October 29, 2019 | finance.yahoo.comIs ReNeuron Group's (LON:RENE) 134% Share Price Increase Well Justified?See More Headlines Receive RNUGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ReNeuron Group and its competitors with MarketBeat's FREE daily newsletter. Email Address RNUGF Company Calendar Today10/01/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RNUGF Previous SymbolNASDAQ:RNUGF CUSIPN/A CIKN/A Webwww.reneuron.com Phone44-20-3819-8400FaxN/AEmployees26Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$540,000.00 Price / Sales9.74 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares57,170,000Free FloatN/AMarket Cap$5.26 million OptionableNot Optionable Beta0.99 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Iain Gladstone Ross B.Sc. (Age 69)BSc (Hons), C.DIR, CH.D, Exec. Chairman Comp: $532.55kMr. John Michael Hawkins A.C.A. (Age 56)Company Sec., CFO & Director Comp: $238.92kDr. John David Sinden B.A. (Age 72)BA, M.A., MA, Ph.D., Co-Founder Ms. Suzanne HancockChief Operations OfficerDr. Randolph Corteling Ph.D.Chief Scientific OfficerMr. Simon DewChief Bus. OfficerMore ExecutivesKey CompetitorsMDxHealthOTCMKTS:MXDHFGreen Organic DutchmanOTCMKTS:TGODFPreveCeutical MedicalOTCMKTS:PRVCFPoxelOTCMKTS:PXXLFBZAMOTCMKTS:BZAMFView All Competitors RNUGF Stock - Frequently Asked Questions How have RNUGF shares performed in 2023? ReNeuron Group's stock was trading at $0.10 at the start of the year. Since then, RNUGF shares have decreased by 8.0% and is now trading at $0.0920. View the best growth stocks for 2023 here. What is ReNeuron Group's stock symbol? ReNeuron Group trades on the OTCMKTS under the ticker symbol "RNUGF." How do I buy shares of ReNeuron Group? Shares of RNUGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ReNeuron Group's stock price today? One share of RNUGF stock can currently be purchased for approximately $0.09. How much money does ReNeuron Group make? ReNeuron Group (OTCMKTS:RNUGF) has a market capitalization of $5.26 million and generates $540,000.00 in revenue each year. How can I contact ReNeuron Group? ReNeuron Group's mailing address is Pencoed Business Park Bridgend, Pencoed X0, CF35 5HY. The official website for the company is www.reneuron.com. The company can be reached via phone at 44-20-3819-8400 or via email at reneuron@walbrookpr.com. This page (OTCMKTS:RNUGF) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReNeuron Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.